These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 17253479

  • 21. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE.
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [Abstract] [Full Text] [Related]

  • 22. Influenza virus neuraminidase inhibitors.
    Gubareva LV, Kaiser L, Hayden FG.
    Lancet; 2000 Mar 04; 355(9206):827-35. PubMed ID: 10711940
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antivirals for influenza in healthy adults: systematic review.
    Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A.
    Lancet; 2006 Jan 28; 367(9507):303-13. PubMed ID: 16443037
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K.
    Health Technol Assess; 2009 Feb 28; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
    Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, Ades AE, Sutton A, Cooper N, Elliot AJ, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S.
    Health Technol Assess; 2009 Nov 28; 13(58):1-265, iii-iv. PubMed ID: 19954682
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness.
    Pitts SR.
    Ann Emerg Med; 2002 May 28; 39(5):552-4. PubMed ID: 11973564
    [No Abstract] [Full Text] [Related]

  • 39. Oseltamivir: a review of its use in influenza.
    McClellan K, Perry CM.
    Drugs; 2001 May 28; 61(2):263-83. PubMed ID: 11270942
    [Abstract] [Full Text] [Related]

  • 40. Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom.
    Sander B, Gyldmark M, Hayden FG, Morris J, Mueller E, Bergemann R.
    Eur J Health Econ; 2005 Sep 28; 6(3):244-52. PubMed ID: 15875227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.